-
1
-
-
61649097962
-
Theoretic applicability of antisensemediated exon skipping for Duchenne muscular dystrophy mutations
-
AARTSMA-RUS, A., FOKKEMA, I., VERSCHUUREN, J., GINJAAR, I., et al. (2009). Theoretic applicability of antisensemediated exon skipping for Duchenne muscular dystrophy mutations. Hum. Mutat. 30, 293-299.
-
(2009)
Hum. Mutat
, vol.30
, pp. 293-299
-
-
Aartsma-Rus, A.1
Fokkema, I.2
Verschuuren, J.3
Ginjaar, I.4
-
2
-
-
33746928462
-
Exploring the Frontiers of Therapeutic Exon Skipping for Duchenne Muscular Dystrophy by Double Targeting within One or Multiple Exons
-
DOI 10.1016/j.ymthe.2006.02.022, PII S1525001606001298
-
AARTSMA-RUS, A., KAMAN, W.E., WEIJ, R., DEN DUNNEN, J.T., et al. (2006). Exploring the frontiers of therapeutic exon skipping for Duchenne muscular dystrophy by double targeting within one or multiple exons. Mol. Ther. 14, 401-407. (Pubitemid 44184959)
-
(2006)
Molecular Therapy
, vol.14
, Issue.3
, pp. 401-407
-
-
Aartsma-Rus, A.1
Kaman, W.E.2
Weij, R.3
Den Dunnen, J.T.4
Van Ommen, G.-Jan.B.5
Van Deutekom, J.C.T.6
-
3
-
-
34748906143
-
Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications
-
DOI 10.1261/rna.653607
-
AARTSMA-RUS, A., and VAN OMMEN, G.J. (2007). Antisensemediated exon skipping: A versatile tool with therapeutic and research applications. RNA 13, 1609-1624. (Pubitemid 47481669)
-
(2007)
RNA
, vol.13
, Issue.10
, pp. 1609-1624
-
-
Aartsma-Rus, A.1
Van Ommen, G.-J.B.2
-
4
-
-
32244443828
-
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
-
DOI 10.1038/nm1345, PII NM1345
-
ALTER, J., LOU, F., RABINOWITZ, A., YIN, H., et al. (2006). Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology. Nat. Med. 12, 175-177. (Pubitemid 43214742)
-
(2006)
Nature Medicine
, vol.12
, Issue.2
, pp. 175-177
-
-
Alter, J.1
Lou, F.2
Rabinowitz, A.3
Yin, H.4
Rosenfeld, J.5
Wilton, S.D.6
Partridge, T.A.7
Qi, L.L.8
-
5
-
-
34547167416
-
Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide - Morpholino oligomer conjugate
-
DOI 10.1021/bc070060v
-
AMANTANA, A., MOULTON, H.M., CATE M.L., REDDY M.T., et al. (2007). Pharmacokinetics, biodistribution, stability and toxicity of a cell-penetrating peptide-morpholino oligomer conjugate. Bioconjug. Chem. 18, 1325-1331. (Pubitemid 47122656)
-
(2007)
Bioconjugate Chemistry
, vol.18
, Issue.4
, pp. 1325-1331
-
-
Amantana, A.1
Moulton, H.M.2
Cate, M.L.3
Reddy, M.T.4
Whitehead, T.5
Hassinger, J.N.6
Youngblood, D.S.7
Iversen, P.L.8
-
6
-
-
78049472917
-
In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse
-
AOKI, Y., NAKAMURA, A., YOKOTA, T., SAITO, T., et al. (2010). In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse. Mol. Ther. 18, 1995-2005.
-
(2010)
Mol. Ther
, vol.18
, pp. 1995-2005
-
-
Aoki, Y.1
Nakamura, A.2
Yokota, T.3
Saito, T.4
-
7
-
-
33846924058
-
Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy
-
DOI 10.1002/humu.20428
-
BEROUD, C., TUFFERY-GIRAUD, S., MATSUO, M., HAMROUN, D., et al. (2006). Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy. Hum. Mutat. 28, 196-202. (Pubitemid 46233317)
-
(2007)
Human Mutation
, vol.28
, Issue.2
, pp. 196-202
-
-
Beroud, C.1
Tuffery-Giraud, S.2
Matsuo, M.3
Hamroun, D.4
Humbertclaude, V.5
Monnier, N.6
Moizard, M.-P.7
Voelckel, M.-A.8
Calemard, L.M.9
Boisseau, P.10
Blayau, M.11
Philippe, C.12
Cossee, M.13
Pages, M.14
Rivier, F.15
Danos, O.16
Garcia, L.17
Claustres, M.18
-
8
-
-
0042242582
-
ESEfinder: A web resource to identify exonic splicing enhancers
-
DOI 10.1093/nar/gkg616
-
CARTEGNI, L., WANG, J., ZHU, Z., ZHANG, M.Q., et al. (2003). ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 31, 3568-3571. (Pubitemid 37442199)
-
(2003)
Nucleic Acids Research
, vol.31
, Issue.13
, pp. 3568-3571
-
-
Cartegni, L.1
Wang, J.2
Zhu, Z.3
Zhang, M.Q.4
Krainer, A.R.5
-
9
-
-
80051690306
-
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: An open-label, phase 2, dose-escalation study
-
CIRAK, S., ARECHAVALA-GOMEZA, V., GUGLIERI, M., FENG, L., et al. (2011). Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. Lancet 378, 595-605.
-
(2011)
Lancet
, vol.378
, pp. 595-605
-
-
Cirak, S.1
Arechavala-Gomeza, V.2
Guglieri, M.3
Feng, L.4
-
10
-
-
36048945922
-
ImageJ for microscopy
-
COLLINS, T.J. (2007). ImageJ for microscopy. Biotechniques 43, 25-30.
-
(2007)
Biotechniques
, vol.43
, pp. 25-30
-
-
Collins, T.J.1
-
11
-
-
78651068846
-
Diaphragm rescue alone prevents heart dysfunction in dystrophic mice
-
CRISP, A., YIN, H., GOYENVALLE, A., BETTS, C., et al. (2011). Diaphragm rescue alone prevents heart dysfunction in dystrophic mice. Hum. Mol. Genet. 20, 413-421.
-
(2011)
Hum. Mol. Genet
, vol.20
, pp. 413-421
-
-
Crisp, A.1
Yin, H.2
Goyenvalle, A.3
Betts, C.4
-
12
-
-
80052668013
-
The pathology of paralysis with muscular degeneration (paralysie myosclerotique), or paralysis with apparent hypertrophy
-
DUCHENNE.
-
DUCHENNE. (1867). The pathology of paralysis with muscular degeneration (paralysie myosclerotique), or paralysis with apparent hypertrophy. Br. Med. J. 2, 541-542.
-
(1867)
Br. Med. J
, vol.2
, pp. 541-542
-
-
-
13
-
-
0031800293
-
Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides
-
DOI 10.1093/hmg/7.7.1083
-
DUNCKLEY, M.G., MANOHARAN, M., VILLIET, P., EPERON, I.C., et al. (1998). Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. Hum. Mol. Genet. 7, 1083-1090. (Pubitemid 28306871)
-
(1998)
Human Molecular Genetics
, vol.7
, Issue.7
, pp. 1083-1090
-
-
Dunckley, M.G.1
Manoharan, M.2
Villiet, P.3
Eperon, I.C.4
Dickson, G.5
-
14
-
-
79955158683
-
Systemic administration of PRO051 in Duchenne's muscular dystrophy
-
GOEMANS, N.M., TULINIUS, M., VAN DEN AKKER, J.T., BURM, B.E., et al. (2011). Systemic administration of PRO051 in Duchenne's muscular dystrophy. N. Engl. J. Med. 364, 1513-1522.
-
(2011)
N. Engl. J. Med
, vol.364
, pp. 1513-1522
-
-
Goemans, N.M.1
Tulinius, M.2
Van Den Akker, J.T.3
Burm, B.E.4
-
15
-
-
74149093605
-
Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomermediated exon-skipping
-
GOYENVALLE, A., BABBS, A., POWELL, D., KOLE, R., et al. (2010). Prevention of dystrophic pathology in severely affected dystrophin/utrophin- deficient mice by morpholino-oligomermediated exon-skipping. Mol. Ther. 18, 198-205.
-
(2010)
Mol. Ther
, vol.18
, pp. 198-205
-
-
Goyenvalle, A.1
Babbs, A.2
Powell, D.3
Kole, R.4
-
16
-
-
79956046546
-
Therapeutic approaches to muscular dystrophy
-
GOYENVALLE, A., SETO, J.T., DAVIES, K.E., and CHAMBERLAIN, J. (2011). Therapeutic approaches to muscular dystrophy. Hum. Mol. Genet. 20, R69-78.
-
(2011)
Hum. Mol. Genet
, vol.20
-
-
Goyenvalle, A.1
Seto, J.T.2
Davies, K.E.3
Chamberlain, J.4
-
17
-
-
80052513011
-
Restoring dystrophin expression in Duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through
-
HOFFMAN, E.P., BRONSON, A., LEVIN, A.A., TAKEDA, S., et al. (2011). Restoring dystrophin expression in Duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through. Am. J. Pathol. 179, 12-22.
-
(2011)
Am. J. Pathol
, vol.179
, pp. 12-22
-
-
Hoffman, E.P.1
Bronson, A.2
Levin, A.A.3
Takeda, S.4
-
18
-
-
0023614188
-
Dystrophin: The protein product of the Duchenne muscular dystrophy locus
-
HOFFMAN, E.P., BROWN, R.H., JR., and KUNKEL, L.M. (1987). Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51, 919-928.
-
(1987)
Cell
, vol.51
, pp. 919-928
-
-
Hoffman, E.P.1
Brown Jr., R.H.2
Kunkel, L.M.3
-
19
-
-
50549093417
-
Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice
-
JEARAWIRIYAPAISARN, N., MOULTON, H.M., BUCKLEY, B., ROBERTS, J., et al. (2008). Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. Mol. Ther. 16, 1624-1629.
-
(2008)
Mol. Ther
, vol.16
, pp. 1624-1629
-
-
Jearawiriyapaisarn, N.1
Moulton, H.M.2
Buckley, B.3
Roberts, J.4
-
20
-
-
74249109987
-
Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers
-
JEARAWIRIYAPAISARN, N., MOULTON, H.M., SAZANI, P., KOLE, R., et al. (2010). Long-term improvement in mdx cardiomyopathy after therapy with peptide-conjugated morpholino oligomers. Cardiovasc. Res. 85, 444-453.
-
(2010)
Cardiovasc. Res
, vol.85
, pp. 444-453
-
-
Jearawiriyapaisarn, N.1
Moulton, H.M.2
Sazani, P.3
Kole, R.4
-
21
-
-
69949107887
-
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: A single-blind, placebo-controlled, dose-escalation, proof-of-concept study
-
KINALI, M., ARECHAVALA-GOMEZA, V., FENG, L., CIRAK, S., et al. (2009). Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. Lancet Neurol. 8, 918-928.
-
(2009)
Lancet Neurol
, vol.8
, pp. 918-928
-
-
Kinali, M.1
Arechavala-Gomeza, V.2
Feng, L.3
Cirak, S.4
-
22
-
-
0023614271
-
Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals
-
DOI 10.1016/0092-8674(87)90504-6
-
KOENIG, M., HOFFMAN, E.P., BERTELSON, C.J., MONACO, A.P., et al. (1987). Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50, 509-517. (Pubitemid 18098338)
-
(1987)
Cell
, vol.50
, Issue.3
, pp. 509-517
-
-
Koening, M.1
Hoffman, E.P.2
Bertelson, C.J.3
Monaco, A.P.4
Feener, C.5
Kunkel, L.M.6
-
23
-
-
11844256373
-
Systemic delivery of antisense oligoribonucleotide restorers dystrophin expression in body-wide skeletal muscles
-
DOI 10.1073/pnas.0406700102
-
LU, Q.L., RABINOWITZ, A., CHEN, Y.C., YOKOTA, T., et al. (2005). Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. Proc. Natl. Acad. Sci. U. S. A. 102, 198-203. (Pubitemid 40094452)
-
(2005)
Proceedings of the National Academy of Sciences of the United States of America
, vol.102
, Issue.1
, pp. 198-203
-
-
Qi, L.L.1
Rabinowitz, A.2
Yun, C.C.3
Yokota, T.4
Yin, H.5
Alter, J.6
Jadoon, A.7
Bou-Gharios, G.8
Partridge, T.9
-
24
-
-
78650916689
-
The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy
-
LU, Q.L., YOKOTA, T., TAKEDA, S., GARCIA, L., et al. (2011). The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy. Mol. Ther. 19, 9-15.
-
(2011)
Mol. Ther
, vol.19
, pp. 9-15
-
-
U, Q.L.L.1
Yokota, T.2
Takeda, S.3
Garcia, L.4
-
25
-
-
33745479703
-
Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD
-
DOI 10.1038/sj.gt.3302800, PII 3302800
-
MCCLOREY, G., MOULTON, H.M., IVERSEN, P.L., FLETCHER, S., et al. (2006). Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD. Gene Ther. 13, 1373-1381.1373-1381. (Pubitemid 44420632)
-
(2006)
Gene Therapy
, vol.13
, Issue.19
, pp. 1373-1381
-
-
McClorey, G.1
Moulton, H.M.2
Iversen, P.L.3
Fletcher, S.4
Wilton, S.D.5
-
26
-
-
58149339903
-
Vivo-Morpholinos: A non-peptide transporter delivers Morpholinos into a wide array of mouse tissues
-
616, 618 passim
-
MORCOS, P.A., LI, Y., and JIANG, S. (2008). Vivo-Morpholinos: a non-peptide transporter delivers Morpholinos into a wide array of mouse tissues. Biotechniques 45, 613-614, 616, 618 passim.
-
(2008)
Biotechniques
, vol.45
, pp. 613-614
-
-
Morcos, P.A.1
L, I.Y.2
Jiang, S.3
-
27
-
-
77958152873
-
Morpholinos and their peptide conjugates: Therapeutic promise and challenge for Duchenne muscular dystrophy
-
MOULTON, H.M., and MOULTON, J.D. (2010). Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy. Biochim. Biophys. Acta 1798, 2296-2303.
-
(2010)
Biochim. Biophys. Acta
, vol.1798
, pp. 2296-2303
-
-
Moulton, H.M.1
Moulton, J.D.2
-
28
-
-
70349453645
-
Peptide-morpholino conjugate: A promising therapeutic for Duchenne muscular dystrophy
-
MOULTON, H.M., WU, B., JEARAWIRIYAPAISARN, N., SAZANI, P., et al. (2009). Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophy. Ann. N. Y. Acad. Sci. 1175, 55-60.
-
(2009)
Ann. N. Y. Acad. Sci
, vol.1175
, pp. 55-60
-
-
Moulton, H.M.1
W, U.B.2
Jearawiriyapaisarn, N.3
Sazani, P.4
-
29
-
-
63449133262
-
Gene knockdowns in adult animals: PPMOs and vivo-morpholinos
-
MOULTON, J.D., and JIANG, S. (2009). Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules 14, 1304-1323.
-
(2009)
Molecules
, vol.14
, pp. 1304-1323
-
-
Moulton, J.D.1
Jiang, S.2
-
30
-
-
44249125023
-
Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene
-
NAKAMURA, A., YOSHIDA, K., FUKUSHIMA, K., UEDA, H., et al. (2008). Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene. J. Clin. Neurosci. 15, 757-763.
-
(2008)
J. Clin. Neurosci
, vol.15
, pp. 757-763
-
-
Nakamura, A.1
Yoshida, K.2
Fukushima, K.3
Ueda, H.4
-
31
-
-
80052435477
-
Impending therapies for Duchenne muscular dystrophy
-
PARTRIDGE, T.A. (2011). Impending therapies for Duchenne muscular dystrophy. Curr. Opin. Neurol. 24, 415-422.
-
(2011)
Curr. Opin. Neurol
, vol.24
, pp. 415-422
-
-
Partridge, T.A.1
-
32
-
-
79955618736
-
Current status of pharmaceutical and genetic therapeutic approaches to treat DMD
-
PICHAVANT, C., AARTSMA-RUS, A., CLEMENS, P.R., DAVIES, K.E., et al. (2011). Current status of pharmaceutical and genetic therapeutic approaches to treat DMD. Mol. Ther. 19, 830-840.
-
(2011)
Mol. Ther
, vol.19
, pp. 830-840
-
-
Pichavant, C.1
Aartsma-Rus, A.2
Clemens, P.R.3
Davies, K.E.4
-
33
-
-
0030582315
-
Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence
-
DOI 10.1006/bbrc.1996.1375
-
PRAMONO, Z.A., TAKESHIMA, Y., ALIMSARDJONO, H., ISHII, A., et al. (1996). Induction of exon skipping of the dystrophin transcript in lymphoblastoid cells by transfecting an antisense oligodeoxynucleotide complementary to an exon recognition sequence. Biochem. Biophys. Res. Commun. 226, 445-449. (Pubitemid 26331921)
-
(1996)
Biochemical and Biophysical Research Communications
, vol.226
, Issue.2
, pp. 445-449
-
-
Pramono, Z.A.D.1
Takeshima, Y.2
Alimsardjono, H.3
Ishii, A.4
Takeda, S.-I.5
Matsuo, M.6
-
34
-
-
0027976166
-
An explanation for the constitutive exon 9 cassette splicing of the DMD gene
-
REISS, J., and RININSLAND, F. (1994). An explanation for the constitutive exon 9 cassette splicing of the DMD gene. Hum. Mol. Genet. 3, 295-298. (Pubitemid 24060945)
-
(1994)
Human Molecular Genetics
, vol.3
, Issue.2
, pp. 295-298
-
-
Reiss, J.1
Rininsland, F.2
-
35
-
-
77957913755
-
Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient
-
SAITO, T., NAKAMURA, A., AOKI, Y., YOKOTA, T., et al. (2010). Antisense PMO found in dystrophic dog model was effective in cells from exon 7-deleted DMD patient. PLoS One 5, e12239.
-
(2010)
PLoS One
, vol.5
-
-
Saito, T.1
Nakamura, A.2
Aoki, Y.3
Yokota, T.4
-
36
-
-
0026538578
-
An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy
-
SHARP, N.J., KORNEGAY, J.N., VAN CAMP, S.D., HERBSTREITH, M.H., et al. (1992). An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 13, 115-121.
-
(1992)
Genomics
, vol.13
, pp. 115-121
-
-
Sharp, N.J.1
Kornegay, J.N.2
Van Camp, S.D.3
Herbstreith, M.H.4
-
37
-
-
0038117843
-
J)
-
DOI 10.1538/expanim.52.93
-
SHIMATSU, Y., KATAGIRI, K., FURUTA, T., NAKURA, M., et al. (2003). Canine X-linked muscular dystrophy in Japan (CXMDJ). Exp. Anim. 52, 93-97. (Pubitemid 41349972)
-
(2003)
Experimental Animals
, vol.52
, Issue.2
, pp. 93-97
-
-
Shimatsu, Y.1
Katagiri, K.2
Furuta, T.3
Nakura, M.4
Tanioka, Y.5
Yuasa, K.6
Tomohiro, M.7
Kornegay, J.N.8
Nonaka, I.9
Takeda, S.10
-
38
-
-
84863393197
-
A Simplified Immune Suppression Scheme Leads to Persistent Micro-dystrophin Expression in Duchenne Muscular Dystrophy Dogs
-
SHIN, J.H., YUE, Y., SRIVASTAVA, A., SMITH, B., et al. (2012). A Simplified Immune Suppression Scheme Leads to Persistent Micro-dystrophin Expression in Duchenne Muscular Dystrophy Dogs. Hum. Gene Ther. 23, 202-209.
-
(2012)
Hum. Gene Ther
, vol.23
, pp. 202-209
-
-
Shin, J.H.1
Yue, Y.2
Srivastava, A.3
Smith, B.4
-
39
-
-
80053898946
-
Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy
-
TANIGUCHI-IKEDA, M., KOBAYASHI, K., KANAGAWA, M., YU, C.C., et al. (2011). Pathogenic exon-trapping by SVA retrotransposon and rescue in Fukuyama muscular dystrophy. Nature 478, 127-131.
-
(2011)
Nature
, vol.478
, pp. 127-131
-
-
Taniguchi-Ikeda, M.1
Kobayashi, K.2
Kanagawa, M.3
U, C.C.Y.4
-
40
-
-
37549034298
-
Local dystrophin restoration with antisense oligonucleotide PRO051
-
VAN DEUTEKOM, J.C., JANSON, A.A., GINJAAR, I.B., FRANKHUIZEN, W.S., et al. (2007). Local dystrophin restoration with antisense oligonucleotide PRO051. N. Engl. J. Med. 357, 2677-286.
-
(2007)
N. Engl. J. Med
, vol.357
, pp. 2677-3286
-
-
Van Deutekom, J.C.1
Janson, A.A.2
Ginjaar, I.B.3
Frankhuizen, W.S.4
-
41
-
-
34249276065
-
Sustained AAV-mediated dystrophin expression in a canine model of duchenne muscular dystrophy with a brief course of immunosuppression
-
DOI 10.1038/sj.mt.6300161, PII 6300161
-
WANG, Z., KUHR, C.S., ALLEN, J.M., BLANKINSHIP, M., et al. (2007). Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression. Mol. Ther. 15, 1160-1166. (Pubitemid 46813619)
-
(2007)
Molecular Therapy
, vol.15
, Issue.6
, pp. 1160-1166
-
-
Wang, Z.1
Kuhr, C.S.2
Allen, J.M.3
Blankinship, M.4
Gregorevic, P.5
Chamberlain, J.S.6
Tapscott, S.J.7
Storb, R.8
-
42
-
-
80052911776
-
An octaguanidine-morpholino oligo conjugate improves muscle function of mdx mice
-
WIDRICK, J.J., JIANG, S., CHOI, S.J., KNUTH, S.T., et al. (2011). An octaguanidine-morpholino oligo conjugate improves muscle function of mdx mice. Muscle Nerve 44, 563-570.
-
(2011)
Muscle Nerve
, vol.44
, pp. 563-570
-
-
Widrick, J.J.1
Jiang, S.2
Choi, S.J.3
Knuth, S.T.4
-
43
-
-
79956070948
-
Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development
-
WU, B., BENRASHID, E., LU, P., CLOER, C., et al. (2011a). Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development. PLoS One 6, e19906.
-
(2011)
PLoS One
, vol.6
-
-
W, U.B.1
Benrashid, E.2
L, U.P.3
Cloer, C.4
-
44
-
-
67349137953
-
Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice
-
WU, B., LI, Y., MORCOS, P.A., DORAN, T.J., et al. (2009). Octa-guanidine morpholino restores dystrophin expression in cardiac and skeletal muscles and ameliorates pathology in dystrophic mdx mice. Mol. Ther. 17, 864-871.
-
(2009)
Mol. Ther
, vol.17
, pp. 864-871
-
-
W, U.B.1
L, I.Y.2
Morcos, P.A.3
Doran, T.J.4
-
45
-
-
74349109205
-
Dosedependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino
-
WU, B., LU, P., BENRASHID, E., MALILK, S., et al. (2010). Dosedependent restoration of dystrophin expression in cardiac muscle of dystrophic mice by systemically delivered morpholino. Gene Ther. 17, 132-140.
-
(2010)
Gene Ther
, vol.17
, pp. 132-140
-
-
W, U.B.1
L, U.P.2
Benrashid, E.3
Malilk, S.4
-
46
-
-
79952189079
-
Oneyear treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice
-
WU, B., XIAO, B., CLOER, C., SHABAN, M., et al. (2011b). Oneyear treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice. Mol. Ther. 19, 576-583.
-
(2011)
Mol. Ther
, vol.19
, pp. 576-583
-
-
W, U.B.1
Xiao, B.2
Cloer, C.3
Shaban, M.4
-
47
-
-
84865313416
-
Exon skipping for nonsense mutations in Duchenne muscular dystrophy: Too many mutations, too few patients?
-
YOKOTA, T., DUDDY, W., ECHIGOYA, Y., and KOLSKI, H. (2012). Exon skipping for nonsense mutations in Duchenne muscular dystrophy: too many mutations, too few patients? Expert Opin. Biol. Ther.
-
(2012)
Expert Opin. Biol. Ther
-
-
Yokota, T.1
Duddy, W.2
Echigoya, Y.3
Kolski, H.4
-
48
-
-
43449113543
-
Optimizing exon skipping therapies for DMD
-
YOKOTA, T., DUDDY, W., and PARTRIDGE, T. (2007a). Optimizing exon skipping therapies for DMD. Acta Myol. 26, 179-184. Online document at: http://informahealthcare.com/doi/abs/10.1517/14712598.2012.693469 Accessed June 1, 2012. (Pubitemid 351668927)
-
(2007)
Acta Myologica
, vol.26
, Issue.3
, pp. 179-184
-
-
Yokota, T.1
Duddy, W.2
Partridge, T.3
-
49
-
-
79960055339
-
Antisense oligo-mediated multiple exon skipping in a dog model of Duchenne muscular dystrophy
-
YOKOTA, T., HOFFMAN, E.P., and TAKEDA, S. (2011). Antisense oligo-mediated multiple exon skipping in a dog model of Duchenne muscular dystrophy. Methods Mol. Biol. 709, 299-312.
-
(2011)
Methods Mol. Biol
, vol.709
, pp. 299-312
-
-
Yokota, T.1
Hoffman, E.P.2
Takeda, S.3
-
50
-
-
33746899641
-
Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration
-
DOI 10.1242/jcs.03000
-
YOKOTA, T., LU, Q.L., MORGAN, J.E., DAVIES, K.E., et al. (2006). Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J. Cell Sci. 119, 2679-2687. (Pubitemid 44184004)
-
(2006)
Journal of Cell Science
, vol.119
, Issue.13
, pp. 2679-2687
-
-
Yokota, T.1
Lu, Q.-L.2
Morgan, J.E.3
Davies, K.E.4
Fisher, R.5
Takeda, S.6
Partridge, T.A.7
-
51
-
-
63449141811
-
Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs
-
YOKOTA, T., LU, Q.L., PARTRIDGE, T., KOBAYASHI, M., et al. (2009a). Efficacy of systemic morpholino exon-skipping in Duchenne dystrophy dogs. Ann. Neurol. 65, 667-676.
-
(2009)
Ann. Neurol
, vol.65
, pp. 667-676
-
-
Yokota, T.1
U, Q.L.L.2
Partridge, T.3
Kobayashi, M.4
-
52
-
-
34250773365
-
Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy
-
DOI 10.1517/14712598.7.6.831
-
YOKOTA, T., PISTILLI, E., DUDDY, W., and NAGARAJU, K. (2007b). Potential of oligonucleotide-mediated exon-skipping therapy for Duchenne muscular dystrophy. Expert Opin. Biol. Ther. 7, 831-842. (Pubitemid 46954430)
-
(2007)
Expert Opinion on Biological Therapy
, vol.7
, Issue.6
, pp. 831-842
-
-
Yokota, T.1
Pistilli, E.2
Duddy, W.3
Nagaraju, K.4
-
53
-
-
58449122870
-
A renaissance for antisense oligonucleotide drugs in neurology: Exon skipping breaks new ground
-
YOKOTA, T., TAKEDA, S., LU, Q.L., PARTRIDGE, T.A., et al. (2009b). A renaissance for antisense oligonucleotide drugs in neurology: exon skipping breaks new ground. Arch. Neurol. 66, 32-38.
-
(2009)
Arch. Neurol
, vol.66
, pp. 32-38
-
-
Yokota, T.1
Takeda, S.2
U, Q.L.L.3
Partridge, T.A.4
-
54
-
-
0016769512
-
Newborn screening for Duchenne muscular dystrophy
-
ZELLWEGER, H., and ANTONIK, A. (1975). Newborn screening for Duchenne muscular dystrophy. Pediatrics 55, 30-34.
-
(1975)
Pediatrics
, vol.55
, pp. 30-34
-
-
Zellweger, H.1
Antonik, A.2
|